In view of the traditional and pharmacological evidence that curcumin is involved in regulating and modulating various inflammatory pathways including JAK/STAT/SOCS signaling, one can confirm curcumin to be a promising therapeutic natural biomolecule in dermatological applications such as treating AD and related proliferative skin infections. This evidence concerns the gene SOAT1 and Alzheimer disease.